Effect of lactate infusions on patients with myasthenia gravis.
D001639:Bicarbonates / Q000097:blood; D002712:Chlorides / Q000097:blood; D006801:Humans; D007263:Infusions, Parenteral; D007511:Ischemia / Q000378:metabolism; D007773:Lactates / Q000097:blood* / Q000378:metabolism / Q000494:pharmacology; D008274:Magnesium / Q000097:blood; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000098:blood supply / Q000187:drug effects / Q000378:metabolism*; D009157:Myasthenia Gravis / Q000097:blood / Q000378:metabolism* / Q000503:physiopathology; D005082:Physical Exertion; D011188:Potassium / Q000097:blood; D011773:Pyruvates / Q000097:blood; D012964:Sodium / Q000097:blood; D013997:Time Factors; D014797:Vital Capacity
D001639:Bicarbonates; D002712:Chlorides; D007773:Lactates; D011773:Pyruvates; D012964:Sodium; D008274:Magnesium; D011188:Potassium